Tristel PLC 2023 AR2
The report details Tristel plc's financial and operational performance for the fiscal year ended 30 June 2023, alongside its first Environmental, Social, and Governance (ESG) report. The company achieved a milestone by securing FDA De Novo clearance for its hand-held high-level disinfectant, Tristel ULT, marking its entry into the North American market. Financially, Tristel's revenue increased by 16% to £36.009m, driven by strong growth in its medical device decontamination segment. The newly established ESG strategy outlines commitments to achieve net-zero Scope 1 and 2 emissions by 2030 and Scope 3 by 2045, aligning with the NHS's net-zero target.
Company: Tristel PLC
Sector: Health Care
Country: United Kingdom
Year: 2023
Type: AR2
Pages: 133
Tristel PLC
Annual Report And Financial Statements
The report details Tristel plc's financial and operational performance for the fiscal year ended 30 June 2023, alongside its first Environmental, Social, and Governance (ESG) report. The company achieved a milestone by securing FDA De Novo clearance for its hand-held high-level disinfectant, Tristel ULT, marking its entry into the North American market. Financially, Tristel's revenue increased by 16% to £36.009m, driven by strong growth in its medical device decontamination segment. The newly established ESG strategy outlines commitments to achieve net-zero Scope 1 and 2 emissions by 2030 and Scope 3 by 2045, aligning with the NHS's net-zero target.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2023
Reporting Period
Jul 1, 2022 - Jun 30, 2023
Fiscal Year
2023
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Women on Board
Women in Management
Workplace Fatalities
Net Zero Target
Employees